Search for an orphan drug
Other search option(s)
Marketing authorisation without orphan designation - Europe
- Tradename: Tecentriq
- ATC code : L01XC32
- EU Number: EMEA/H/C/4143
- MA date : 21/09/2017
- MA holder: ROCHE REGISTRATION GMBH
- European Public Assessment Report
Therapeutic indication
As monotherapy for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (UC): after prior platinum containing chemotherapy, or who are considered cisplatin ineligible, and whose tumours have a PD-L1 expression >= 5%
Diseases list
Appraisal/reimbursement
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.